iopamidol has been researched along with ioxilan in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedgpeth, PL; Scanlan, RM; Thurmond, AS | 1 |
| Lasser, EC; Lyon, SG | 1 |
| Parvez, Z; Patel, NB | 1 |
| Foster, SJ; Halkovich, CA; Sovak, M | 1 |
| Haruta, K; Kurata, M; Nakamura, H; Takeda, K | 1 |
| Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O | 1 |
| Fujii, S; Kitabatake, A; Ogawa, T; Urasawa, K | 1 |
| Ener, RA; Fiss, D; Georgakis, A; Jin, J; Kunapuli, S; Leech, SH; Van Decker, WA; Wolf, NM | 1 |
| Aharonian, VJ; Brar, SS; Burchette, RJ; Desai, N; Jorgensen, MB; Kotlewski, A; Ree, M; Shah, AI; Shen, AY | 1 |
| Chicaíza-Becerra, LA; Gamboa, Ó; García-Molina, M | 1 |
1 review(s) available for iopamidol and ioxilan
| Article | Year |
|---|---|
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
Topics: Acute Kidney Injury; Aged; Colombia; Contrast Media; Cost-Benefit Analysis; Decision Trees; Drug Costs; Female; Health Expenditures; Hospitalization; Humans; Insurance, Health, Reimbursement; Iohexol; Iopamidol; Length of Stay; Male; Middle Aged; National Health Programs; Osmolar Concentration; Outpatients; Renal Dialysis; Risk; Triiodobenzoic Acids | 2012 |
1 trial(s) available for iopamidol and ioxilan
| Article | Year |
|---|---|
Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.
Topics: Aged; Contrast Media; Coronary Angiography; Diabetes Mellitus; Female; Glomerular Filtration Rate; Humans; Iohexol; Iopamidol; Male; Renal Insufficiency; Renal Insufficiency, Chronic; Risk Factors; Single-Blind Method; Sodium Bicarbonate; Sodium Chloride | 2008 |
8 other study(ies) available for iopamidol and ioxilan
| Article | Year |
|---|---|
Selective injection of contrast media: inflammatory effects on rabbit fallopian tubes.
Topics: Animals; Contrast Media; Diatrizoate Meglumine; Ethiodized Oil; Fallopian Tubes; Female; Hysterosalpingography; Injections; Iohexol; Iopamidol; Iothalamate Meglumine; Ioxaglic Acid; Rabbits; Salpingitis | 1991 |
Inhibition of angiotensin-converting enzyme by contrast media. I. In vitro findings.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chelating Agents; Contrast Media; Diatrizoate; In Vitro Techniques; Iodipamide; Iohexol; Iopamidol; Iothalamic Acid; Ioxaglic Acid | 1990 |
Effect of a new nonionic contrast agent, ioxilan, on human erythrocytes and the hemostatic and serum complement pathways.
Topics: Complement Activation; Contrast Media; Erythrocytes; Hemostasis; Humans; In Vitro Techniques; Iohexol; Iopamidol | 1988 |
Current contrast media and ioxilan. Comparative evaluation of vascular pain by aversion conditioning.
Topics: Animals; Conditioning, Psychological; Contrast Media; Female; Iohexol; Iopamidol; Osmolar Concentration; Pain; Rats; Rats, Inbred Strains; Sorbitol; Taste | 1988 |
Effects of ionic and nonionic contrast media on cardiohemodynamics and quality of radiographic image during canine angiography.
Topics: Angiography; Animals; Blood Pressure; Cerebral Angiography; Contrast Media; Diatrizoate Meglumine; Dogs; Electrocardiography; Heart Rate; Hemodynamics; Iohexol; Iopamidol; Male | 1994 |
The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan.
Topics: Animals; Contrast Media; Coronary Angiography; Dog Diseases; Dogs; Female; Iohexol; Iopamidol; Male; Osmolar Concentration; Triiodobenzoic Acids; Ventricular Fibrillation | 2000 |
Effects of nonionic contrast media on platelet aggregation: assessment by particle counting with laser-light scattering.
Topics: Angiography; Contrast Media; Female; Flow Cytometry; Humans; Iohexol; Iopamidol; Male; Osmolar Concentration; Particle Size; Platelet Activation; Platelet Aggregation; Scattering, Radiation; Scintillation Counting; Thrombosis | 2001 |
Risk of thrombogenicity among nonionic radiocontrast agents.
Topics: Blood Platelets; Cardiac Catheterization; Contrast Media; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Iohexol; Iopamidol; Platelet Aggregation; Risk Factors; Triiodobenzoic Acids | 2008 |